Adipogen/anti-TLR4 (human), mAb (ABM19C4) (APC)/AG-20T-0303C-C100/100 ?g
一抗
商品編號
AG-20T-0303C-C100
品牌
Adipogen
公司
Adipogen
公司分類(lèi)
Antibodies
Size
100 ?g
商品信息
More Information
Product Details
Synonyms
Toll-like Receptor 4; TOLL; hToll; CD284; ARMD10
Product Type
Monoclonal Antibody
Properties
Clone
ABM19C4
Isotype
Mouse IgG2bκ
Immunogen/Antigen
Recombinant human TLR4 protein (aa 45-320).
Label/Conjugates
APC
Application
Flow Cytometry:
(0.5-1μg/10
6
cells).
Optimal conditions must be determined individually for each application.
Crossreactivity
Human
Specificity
Recognizes human TLR4.
Purity
Protein G purified.
Concentration
0.2mg/ml
Formulation
Liquid. In PBS containing 0.05% sodium azide.
Accession Number
O00206
Shipping and Handling
Shipping
BLUE ICE
Short Term Storage
+4°C
Long Term Storage
+4°C
Handling Advice
Do not freeze.
Protect from light.
Use/St
ABI
lity
Stable for at least 6 months after receipt when stored at +4°C.
Documents
MSD
S
No
Product Specification Sheet
Datasheet
Download PDF
TLR4 (Toll-like Receptor 4) is a member of the Toll-like receptor (TLR) family which plays a fundamental role in pathogen recognition and activation of innate immunity. It was the first TLR identified TLR in mammals and most studied member of the TLR family. TLR4 recognizes the active lipid A component of lipopolysaccharide (LPS) from Gram-negative bacteria in conjunction with LY96 (also referred to MD-2), CD14 and LPS-binding protein (LBP) and consequently mediates the innate immune response to bacterial lipopolysaccharide (LPS). Additionally, it is also involved in LPS-independent responses triggered by endogenous DMAPs, such as heat shock proteins (HSPs) or HMGB1. TLR4 signals via MYD88, TIRAP and TRAF6, le
ADI
ng to NF-κB activation, cytokine secretion and the inflammatory response in various cell types. In complex with TLR6, it was shown to promote sterile inflammation in monocytes/macrophages in response to oxidized low-density lipoprotein (oxLDL) or amyloid-β 42. TLR4-mediated inflammation, triggered by exogenous or endogenous ligands, is involved in several acute and chronic diseases, having a pivotal role as amplifier of the inflammatory response. The potency with which this TLR activates inflammatory pathways makes it an ideal target for therapeutic intervention and adjuvant development. A broad range of clinical studies have examined the adjuvant activity of TLR4 activators in vaccines against infectious and tumor antigens.
產(chǎn)品貨號:4268.0